Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation.
Identifieur interne : 001261 ( PubMed/Corpus ); précédent : 001260; suivant : 001262Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation.
Auteurs : Brad Hagen ; Chris Armstrong Esther ; Roland Ikuta ; Robert J. Williams ; Carole-Lynne Le Navenec ; Morgan AhoSource :
- International psychogeriatrics [ 1041-6102 ] ; 2005.
English descriptors
- KwdEn :
- Adaptation, Psychological (drug effects), Aged, Aged, 80 and over, Analysis of Variance, Antipsychotic Agents (administration & dosage), Canada (epidemiology), Dementia (drug therapy), Humans, Life Change Events, Long-Term Care (psychology), Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Patient Transfer, Prevalence, Residential Facilities, Stress, Psychological (drug therapy), Stress, Psychological (epidemiology), Stress, Psychological (etiology).
- MESH :
- chemical , administration & dosage : Antipsychotic Agents.
- geographic , epidemiology : Canada.
- drug effects : Adaptation, Psychological.
- drug therapy : Dementia, Parkinson Disease, Stress, Psychological.
- epidemiology : Parkinson Disease, Stress, Psychological.
- etiology : Stress, Psychological.
- psychology : Long-Term Care.
- Aged, Aged, 80 and over, Analysis of Variance, Humans, Life Change Events, Patient Transfer, Prevalence, Residential Facilities.
Abstract
Data on antipsychotic use were collected in two Canadian long-term care (LTC) facilities. During the one-year study, residents in one facility were relocated to a new facility, allowing examination of the changes in antipsychotic use associated with relocation.
PubMed: 16050429
Links to Exploration step
pubmed:16050429Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation.</title>
<author><name sortKey="Hagen, Brad" sort="Hagen, Brad" uniqKey="Hagen B" first="Brad" last="Hagen">Brad Hagen</name>
<affiliation><nlm:affiliation>School of Health Sciences, The University of Lethbridge, 4401 University Drive, Lethbridge, Alberta T1K 3M4, Canada. brad.hagen@uleth.ca</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Esther, Chris Armstrong" sort="Esther, Chris Armstrong" uniqKey="Esther C" first="Chris Armstrong" last="Esther">Chris Armstrong Esther</name>
</author>
<author><name sortKey="Ikuta, Roland" sort="Ikuta, Roland" uniqKey="Ikuta R" first="Roland" last="Ikuta">Roland Ikuta</name>
</author>
<author><name sortKey="Williams, Robert J" sort="Williams, Robert J" uniqKey="Williams R" first="Robert J" last="Williams">Robert J. Williams</name>
</author>
<author><name sortKey="Le Navenec, Carole Lynne" sort="Le Navenec, Carole Lynne" uniqKey="Le Navenec C" first="Carole-Lynne" last="Le Navenec">Carole-Lynne Le Navenec</name>
</author>
<author><name sortKey="Aho, Morgan" sort="Aho, Morgan" uniqKey="Aho M" first="Morgan" last="Aho">Morgan Aho</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16050429</idno>
<idno type="pmid">16050429</idno>
<idno type="wicri:Area/PubMed/Corpus">001261</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001261</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation.</title>
<author><name sortKey="Hagen, Brad" sort="Hagen, Brad" uniqKey="Hagen B" first="Brad" last="Hagen">Brad Hagen</name>
<affiliation><nlm:affiliation>School of Health Sciences, The University of Lethbridge, 4401 University Drive, Lethbridge, Alberta T1K 3M4, Canada. brad.hagen@uleth.ca</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Esther, Chris Armstrong" sort="Esther, Chris Armstrong" uniqKey="Esther C" first="Chris Armstrong" last="Esther">Chris Armstrong Esther</name>
</author>
<author><name sortKey="Ikuta, Roland" sort="Ikuta, Roland" uniqKey="Ikuta R" first="Roland" last="Ikuta">Roland Ikuta</name>
</author>
<author><name sortKey="Williams, Robert J" sort="Williams, Robert J" uniqKey="Williams R" first="Robert J" last="Williams">Robert J. Williams</name>
</author>
<author><name sortKey="Le Navenec, Carole Lynne" sort="Le Navenec, Carole Lynne" uniqKey="Le Navenec C" first="Carole-Lynne" last="Le Navenec">Carole-Lynne Le Navenec</name>
</author>
<author><name sortKey="Aho, Morgan" sort="Aho, Morgan" uniqKey="Aho M" first="Morgan" last="Aho">Morgan Aho</name>
</author>
</analytic>
<series><title level="j">International psychogeriatrics</title>
<idno type="ISSN">1041-6102</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adaptation, Psychological (drug effects)</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Analysis of Variance</term>
<term>Antipsychotic Agents (administration & dosage)</term>
<term>Canada (epidemiology)</term>
<term>Dementia (drug therapy)</term>
<term>Humans</term>
<term>Life Change Events</term>
<term>Long-Term Care (psychology)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Patient Transfer</term>
<term>Prevalence</term>
<term>Residential Facilities</term>
<term>Stress, Psychological (drug therapy)</term>
<term>Stress, Psychological (epidemiology)</term>
<term>Stress, Psychological (etiology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antipsychotic Agents</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Adaptation, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dementia</term>
<term>Parkinson Disease</term>
<term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term>
<term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Stress, Psychological</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Long-Term Care</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Aged, 80 and over</term>
<term>Analysis of Variance</term>
<term>Humans</term>
<term>Life Change Events</term>
<term>Patient Transfer</term>
<term>Prevalence</term>
<term>Residential Facilities</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Data on antipsychotic use were collected in two Canadian long-term care (LTC) facilities. During the one-year study, residents in one facility were relocated to a new facility, allowing examination of the changes in antipsychotic use associated with relocation.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16050429</PMID>
<DateCreated><Year>2005</Year>
<Month>07</Month>
<Day>29</Day>
</DateCreated>
<DateCompleted><Year>2005</Year>
<Month>10</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>10</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1041-6102</ISSN>
<JournalIssue CitedMedium="Print"><Volume>17</Volume>
<Issue>2</Issue>
<PubDate><Year>2005</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>International psychogeriatrics</Title>
<ISOAbbreviation>Int Psychogeriatr</ISOAbbreviation>
</Journal>
<ArticleTitle>Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation.</ArticleTitle>
<Pagination><MedlinePgn>179-93</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">Data on antipsychotic use were collected in two Canadian long-term care (LTC) facilities. During the one-year study, residents in one facility were relocated to a new facility, allowing examination of the changes in antipsychotic use associated with relocation.</AbstractText>
<AbstractText Label="METHOD" NlmCategory="METHODS">A comparative descriptive design was used. Pharmacy and chart data on antipsychotic use were gathered for three separate one-month periods during one year. Data were collected both in a facility experiencing relocation of all residents to a new facility, and in a facility not undergoing relocation. The three one-month data collection periods covered a one-month period before the relocation, immediately after the relocation, and six months after the relocation.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In the facility not experiencing relocation, an average of 31.3% of all residents were receiving antipsychotics. Residents in this facility received antipsychotics for an average length of 0.81 years, and 20.8% of all antipsychotic prescriptions reflected dose reductions within six months of the start of the prescription. Only 8.1% of prescriptions had accompanying documentation on the behavioral indication for the use of antipsychotics. A total of 73.4% of all antipsychotics were 'atypical' antipsychotics, and 13.5% of all antipsychotic prescriptions were written as 'p.r.n.' (as needed). While the use of antipsychotics remained relatively constant in the non-relocation facility (between 30.3% and 33.1% of all residents), the percentage of residents receiving antipsychotics in the facility experiencing a relocation climbed significantly; from 21.5% six months before the move, to 32.6% immediately after the move, to 36.9% six months after the move.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These findings, when compared with the U.S. standards on antipsychotic use (OBRA), suggest the need for additional research on antipsychotic use in Canadian LTC facilities.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hagen</LastName>
<ForeName>Brad</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>School of Health Sciences, The University of Lethbridge, 4401 University Drive, Lethbridge, Alberta T1K 3M4, Canada. brad.hagen@uleth.ca</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Esther</LastName>
<ForeName>Chris Armstrong</ForeName>
<Initials>CA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ikuta</LastName>
<ForeName>Roland</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Williams</LastName>
<ForeName>Robert J</ForeName>
<Initials>RJ</Initials>
</Author>
<Author ValidYN="Y"><LastName>Le Navenec</LastName>
<ForeName>Carole-Lynne</ForeName>
<Initials>CL</Initials>
</Author>
<Author ValidYN="Y"><LastName>Aho</LastName>
<ForeName>Morgan</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Int Psychogeriatr</MedlineTA>
<NlmUniqueID>9007918</NlmUniqueID>
<ISSNLinking>1041-6102</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014150">Antipsychotic Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000223" MajorTopicYN="N">Adaptation, Psychological</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014150" MajorTopicYN="N">Antipsychotic Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008016" MajorTopicYN="Y">Life Change Events</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008134" MajorTopicYN="N">Long-Term Care</DescriptorName>
<QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010360" MajorTopicYN="Y">Patient Transfer</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012112" MajorTopicYN="Y">Residential Facilities</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013315" MajorTopicYN="N">Stress, Psychological</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>10</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16050429</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001261 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001261 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:16050429 |texte= Antipsychotic drug use in Canadian long-term care facilities: prevalence, and patterns following resident relocation. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:16050429" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |